Table 2. Statistical analysis of outcome in different groups.
Groups | Parameter | Pre-treatment | Post IVB injection | P |
Focal | Visual acuity LogMAR: x±s | 0.32±0.268 | 0.235±0.27 | 0.040 |
OCT thickness Microns: x±s | 298.8±25.03 | 284.6±24.4 | 0.004 | |
Diffuse | Visual acuity LogMAR: x±s | 0.82±0.73 | 0.80±0.76 | 0.838 |
OCT thickness Microns: x±s | 310.8±40.6 | 291.94±50.1 | 0.021 | |
Focal cystoid | Visual acuity LogMAR: x±s | 0.43±0.16 | 0.53±0.25 | 0.276 |
OCT thickness Microns: x±s | 397.15±31.05 | 374.2±50.23 | 0.208 | |
Neurosensory detachment | Visual acuity LogMAR: x±s | 0.93±0.64 | 0.79±0.62 | 0.490 |
OCT thickness Microns: x±s | 401.03±75.1 | 365.0±57.6 | 0.052 |
IVB: Intravitreal bevacizumab.